← Back to Clinical Trials
Recruiting NCT06699095

Home Rehabilitation As Continuity of Care in MS

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Multiple Sclerosis
Sponsor Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Study Type INTERVENTIONAL
Phase N/A
Enrollment 20
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-11-06
Completion 2025-11-06
Interventions
Telerehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.

Eligibility Criteria

Inclusion Criteria: * Expanded Disability Status Scale score between 3 and 6 * Sensory Organisation Test Equitest values indicating balance impairment Exclusion Criteria: * visual impairments * orthopedic impairments * inability to perform balance rehabilitation in stand up position

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MULTIPLE SCLEROSIS TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}